Metaiodobenzylguanidine (MIBG) was developed initially as a tracer for oncological imaging; when labeled with 123 I or 131 I, it may detect APUDomas, such as pheochromocytomas and paragangliomas. In the last years, MIBG has found an important role also in neurology and cardiology, as cardiac innervation tracer. Actually, MIBG cardiac imaging is a universally accepted method to estimate cardiac sympathetic innervations. This review covers the role of MIBG cardiac imaging in Parkinson disease and parkinsonisms, from the pathophysiological premises for cardiac denervation to new emerging dat
The purpose of this study was to investigate myocardial uptake of 123I-metaiodobenzylguanidine (MIBG...
We studied the relationship between myocardial [123l]metaiodoben-zylguanidine (MIBG) uptake and auto...
The aim of our study was to investigate the relationship between myocardial sympathetic degeneration...
Metaiodobenzylguanidine (MIBG) was developed initially as a tracer for oncological imaging; when lab...
Objectives—123I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy is clini-cally used to estima...
123I-metaiodobenzylguanidine (MIBG) is a radiolabeled norepinephrine analog that can be used to inve...
Cardiac sympathetic activity plays a key role in supporting cardiac function in both health and dise...
Radio-labeled metaiodobenzylguanidine (MIBG) is considered an established sympathetic neuron imaging...
Cardiac amyloidosis is a form of restrictive cardiomyopathy resulting in heart failure and potential...
Myocardial scintigraphy with meta-iodo-benzyl-guanidine (123I cMIBG) has been studied in Parkinson's...
We evaluated the cardiac innervation status of patients with idiopathic Parkinson's disease (IPD), i...
Myocardial MIBG scintigraphy is established in the diagnosis and differential diagnosis of Parkinson...
OBJECTIVE: Differential diagnosis between Parkinson's disease (PD) and other Parkinsonism using clin...
123I-radiolabeled metaiodobenzylguanidine (123I-MIBG) cardiac imaging has been used to evaluate the ...
The purpose of this study was to investigate myocardial uptake of 123I-metaiodobenzylguanidine (MIBG...
We studied the relationship between myocardial [123l]metaiodoben-zylguanidine (MIBG) uptake and auto...
The aim of our study was to investigate the relationship between myocardial sympathetic degeneration...
Metaiodobenzylguanidine (MIBG) was developed initially as a tracer for oncological imaging; when lab...
Objectives—123I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy is clini-cally used to estima...
123I-metaiodobenzylguanidine (MIBG) is a radiolabeled norepinephrine analog that can be used to inve...
Cardiac sympathetic activity plays a key role in supporting cardiac function in both health and dise...
Radio-labeled metaiodobenzylguanidine (MIBG) is considered an established sympathetic neuron imaging...
Cardiac amyloidosis is a form of restrictive cardiomyopathy resulting in heart failure and potential...
Myocardial scintigraphy with meta-iodo-benzyl-guanidine (123I cMIBG) has been studied in Parkinson's...
We evaluated the cardiac innervation status of patients with idiopathic Parkinson's disease (IPD), i...
Myocardial MIBG scintigraphy is established in the diagnosis and differential diagnosis of Parkinson...
OBJECTIVE: Differential diagnosis between Parkinson's disease (PD) and other Parkinsonism using clin...
123I-radiolabeled metaiodobenzylguanidine (123I-MIBG) cardiac imaging has been used to evaluate the ...
The purpose of this study was to investigate myocardial uptake of 123I-metaiodobenzylguanidine (MIBG...
We studied the relationship between myocardial [123l]metaiodoben-zylguanidine (MIBG) uptake and auto...
The aim of our study was to investigate the relationship between myocardial sympathetic degeneration...